Recent Publications: 2009-Present
Alemayehu D, Alvir J, Chappell PB, Knirsch, CA.
A quantitative approach to enhancing risk assessment and mitigation in
Applied Clinical Trials. 2012; 21 (4) 33-35
Alemayehu A, Quinn J, Cook J, Kunkel M, Knirsch CA.
A Paradigm Shift in Drug Development for Treatment of Rare Multidrug
Resistant Gram-Negative Pathogens
Clinical Infectious Diseases. 2012; doi: 10.1093/cid/cis503
Alemayehu D. Assessing exchangeability in indirect and mixed treatment comparisons. Comparative Effectiveness Research. 2011;1: 51 - 55
Alemayehu D. Perspectives on Pooled Data Analysis: the Case for an Integrated Approach. Journal of Data Science. 2011; 9(3): 399-426
Alemayehu D. Trends in Comparative Effectiveness Research. Biopharmaceutical Report. 2011; 18 (1): 15-21
Alemayehu D, Alvir J, Jones B, Willke R. Statistical Issues with the Analysis of Non-Randomized Studies in Comparative Effectiveness Research.
J Manag Care Pharm. 2011;17(9-a):S22-S26.
Alemayehu D, Cappelleri, JC. Revisiting Issues, Drawbacks, and Opportunities with Observational Studies in Comparative Effectiveness Research.
Journal of Evaluation in Clinical Practice. To Appear. 2011.
Alemayehu D, Sanchez R, Cappelleri, JC. Considerations on the Use of Patient-Reported Outcomes in Comparative Effectiveness
Research. J Manag Care Pharm. 2011;17(9-a):S27-S33.
Alemayehu D, Levenstein M. "Toward a Pragmatic Policy on Authorship," Statistics, Politics, and Policy. 201r12; Vol. 2: Iss. 1, Article 6.
DOI: 10.2202/2151-7509.1034. Available at: http://www.bepress.com/spp/vol2/iss1/6
Alemayehu D, Mardekian, J. Infrastructure Requirement for Secondary Data Sources in Comparative Effectiveness Research. J Manag Care Pharm.
Guo J, Alemayehu D, Shao Y. Tests for Normality Based on Entropy Divergences. Statistics in Biopharmaceutical Research. 2010;
Alemayehu D, Andrews EN, Glue P, Knirsch CA. Considerations for the design and conduct of a pharmacovigilance study involving mass drug
>dministration in a resource-constrained setting. PLoS Negl Trop Dis. 2010; 4(1):e564 20126267.
Alemayehu D. Evaluation of Reporting Bias in Postmarketing Risk Assessment Based on Spontaneous Reporting Systems. Pharmaceutical
Medicine. 2009; 3(4):195-200.
Alemayehu D. Current Issues with Covariate Adjustment in the Analysis of Data from Randomized Controlled Trials.
Am J Ther. 2011 Mar-Apr;18(2):153-7.